CervoMed Inc. - ROE
CRVO
Price:
$4.24
Market Cap:
$39.26M
CervoMed Inc., headquartered in Boston, Massachusetts, operates as a clinical-stage biotechnology firm committed to discovering, developing, and ultimately bringing to market pharmaceutical solutions for various neurodegenerative conditions. A central component of their therapeutic pipeline is neflamapimod, an innovative small molecule designed for oral administration and capable of crossing the blood-brain barrier. This compound is currently being advanced as a potential treatment for debilitating ailments such as Lewy body dementia (DLB), Alzheimer's disease, and for aiding recovery following a cerebral stroke.
Industry
Biotechnology
IPO Date
2008-05-23
Stock Exchange
NASDAQ
Ticker
CRVO
PE Ratio
[-1.29]
ROE
[-136.08%]
Current Ratio
[3.36]
Dividend Yield
[0%]
Enterprise Value
[31.32M]
Dividend History
The ROE as of June 2026 (TTM) for CervoMed Inc. (CRVO) is -136.08%
According to CervoMed Inc.’s latest financial reports and current stock price. The company's current ROE is -136.08%. This represents a change of 224.35% compared to the average of -41.96% of the last 4 quarters.
CervoMed Inc. (CRVO) Historical ROE (quarterly & annually)
How has CRVO ROE performed in the past?
The mean historical ROE of CervoMed Inc. over the last ten years is -65.98%. The current -136.08% ROE has changed 106.26% with respect to the historical average. Over the past ten years (40 quarters), CRVO's ROE was at its highest in in the June 2017 quarter at 1.75%. The ROE was at its lowest in in the March 2026 quarter at -75.02%.
Average
-65.98%
Median
-57.88%
Minimum
-196.38%
Maximum
64.49%
CervoMed Inc. (CRVO) ROE by Quarter and Year
Discovering the peaks and valleys of CervoMed Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.73%
Maximum Annual ROE = 64.49%
Minimum Annual Increase = -193.44%
Minimum Annual ROE = -196.38%
| Year | ROE | Change |
|---|---|---|
| 2025 | -147.98% | 256.10% |
| 2024 | -41.56% | 41.14% |
| 2023 | -29.44% | -145.65% |
| 2022 | 64.49% | -193.44% |
| 2021 | -69.02% | 20.74% |
| 2020 | -57.16% | -2.45% |
| 2019 | -58.60% | -50.20% |
| 2018 | -117.67% | 1.73% |
| 2017 | -6.43% | -96.73% |
| 2016 | -196.38% | -101.22% |
CervoMed Inc. (CRVO) Average ROE
How has CRVO ROE performed in the past?
The current ROE of CervoMed Inc. (CRVO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-72.99%
5-year avg
-44.70%
10-year avg
-65.98%
CervoMed Inc. (CRVO) ROE vs. Peers
How is CRVO’s ROE compared to its peers?
CervoMed Inc.’s ROE is greater than Gain Therapeutics, Inc. (-201.43%), greater than Adagene Inc. (-48.20%), greater than XBiotech Inc. (-26.10%), less than OS Therapies Incorporated (3.21%), greater than Nutriband Inc. (-112.60%), greater than Adicet Bio, Inc. (-80.35%), less than NRx Pharmaceuticals, Inc. (107.73%), less than Fortress Biotech, Inc. (163.88%), greater than Lite Strategy, Inc. (-90.81%), less than vTv Therapeutics Inc. (3.96%),
| Company | ROE | Market cap |
|---|---|---|
| -201.43% | $80.19M | |
| -48.20% | $148.34M | |
| -26.10% | $70.43M | |
| 3.21% | $85.96M | |
| -112.60% | $35.25M | |
| -80.35% | $75.72M | |
| 107.73% | $68.62M | |
| 163.88% | $99.33M | |
| -90.81% | $28.17M | |
| 3.96% | $91.71M |
Build a custom stock screener for CervoMed Inc. (CRVO) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like CervoMed Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
CervoMed Inc. (CRVO) and other stocks custom spreadsheet templates
The easiest way to analyze a company like CervoMed Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is CervoMed Inc.'s ROE?
How is the ROE calculated for CervoMed Inc. (CRVO)?
What is the highest ROE for CervoMed Inc. (CRVO)?
What is the 3-year average ROE for CervoMed Inc. (CRVO)?
What is the 5-year average ROE for CervoMed Inc. (CRVO)?
How does the current ROE for CervoMed Inc. (CRVO) compare to its historical average?